Tarbox Family Office, Inc. Spectrum Pharmaceuticals Inc Transaction History

Tarbox Family Office, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$2.89 - $4.45 $1,390 - $2,140	-481 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$1.83 - $3.45 $541 - $1,021	296 Added 160.0%	481 $1,000
Q4 2019 Jan 31, 2020	BUY	$3.5 - $10.35 $647 - $1,914	185 New	185 $1,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.